GlassScriptPhysician profile
Tasha S Chapa
NPI 1225707144
$2,948.83
in general payments reported to CMS, 2019-2025
27 companies · $491 in 2025
The $491 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $658 · 2023: $1,133 · 2024: $667 · 2025: $491.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,291.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,290.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $485.64 | 2022-2025 | Fasenra, Breztri, Airsupra |
| Boston Scientific Corporation | $444.95 | 2023-2024 | Avvigo Guidance System, Rotapro, Comet |
| Glaxosmithkline, LLC. | $346.32 | 2022-2023 | Nucala, Arexvy, Trelegy Ellipta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $240.99 | 2022-2025 | Jardiance, Ofev |
| Novartis Pharmaceuticals Corporation | $182.64 | 2024-2025 | |
| Pfizer INC. | $162.71 | 2024-2025 | |
| Amgen INC. | $156.69 | 2022-2025 | Repatha |
| Bayer Healthcare Pharmaceuticals INC. | $128.28 | 2022-2025 | |
| Electromed, INC. | $123.58 | 2022-2023 | Smartvest |
| Regeneron Healthcare Solutions, INC. | $84.59 | 2022-2024 | Praluent, Evkeeza, Dupixent |
| Mylan Specialty L.P. | $76.92 | 2022-2023 | Yupelri |
| Impulse Dynamics (USA) INC. | $65.76 | 2024 | Optimizer |
| E.R. Squibb & Sons, L.L.C. | $60.64 | 2024-2025 | Camzyos, Eliquis |
| Janssen Pharmaceuticals, INC | $48.94 | 2024 | Xarelto |
| United Therapeutics Corporation | $48.88 | 2022-2023 | Tyvaso |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $40.86 | 2022-2023 | Sunosi |
| Harmony Biosciences LLC | $34.85 | 2022-2023 | Wakix |
| Lexicon Pharmaceuticals, INC. | $31.98 | 2024 | |
| Actelion Pharmaceuticals US, INC. | $30.64 | 2022-2023 | Uptravi, Opsumit |
| Insmed, INC. | $30.26 | 2023 | Arikayce |
| Philips North America LLC | $29.68 | 2022 | |
| Genzyme Corporation | $24.64 | 2023 | |
| Baxter Healthcare | $15.90 | 2023 | Hillrom - Life 2000 Ventilation System |
| Genentech USA, INC. | $14.88 | 2023 | Xolair |
| Abbott Laboratories | $14.18 | 2025 | Cardiomems |
| Inogen, INC. | $12.60 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $10.83 | 2025 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tasha Chapa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.